Marsh & McLennan Companies (NYSE:MMC) PT Raised to $201.00

Marsh & McLennan Companies (NYSE:MMC) had its target price boosted by equities research analysts at TD Cowen from $189.00 to $201.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently has a “hold” rating on the financial services provider’s stock. TD Cowen’s price objective would suggest a potential downside of 0.37% from the company’s previous close.

MMC has been the topic of a number of other reports. Wells Fargo & Company raised their price objective on Marsh & McLennan Companies from $212.00 to $213.00 and gave the company an “equal weight” rating in a research note on Friday, April 19th. Morgan Stanley raised their target price on Marsh & McLennan Companies from $205.00 to $210.00 and gave the stock an “equal weight” rating in a research note on Monday, April 15th. Royal Bank of Canada raised their target price on Marsh & McLennan Companies from $208.00 to $210.00 and gave the stock a “sector perform” rating in a research note on Friday, April 19th. Evercore ISI raised their target price on Marsh & McLennan Companies from $212.00 to $218.00 and gave the stock an “outperform” rating in a research note on Thursday, April 11th. Finally, UBS Group raised their target price on Marsh & McLennan Companies from $236.00 to $238.00 and gave the stock a “buy” rating in a research note on Monday. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $207.69.

Marsh & McLennan Companies Stock Up 0.2 %

Shares of NYSE:MMC opened at $201.74 on Monday. The stock’s 50-day moving average price is $203.07 and its 200-day moving average price is $197.04. Marsh & McLennan Companies has a 12-month low of $171.47 and a 12-month high of $209.20. The stock has a market capitalization of $99.40 billion, a P/E ratio of 25.60, a price-to-earnings-growth ratio of 3.39 and a beta of 0.90. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.97.

Marsh & McLennan Companies (NYSE:MMC) last announced its quarterly earnings data on Thursday, April 18th. The financial services provider reported $2.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.80 by $0.09. Marsh & McLennan Companies had a return on equity of 34.14% and a net margin of 16.84%. The firm had revenue of $6.50 billion for the quarter, compared to analysts’ expectations of $6.38 billion. During the same period last year, the firm earned $2.53 earnings per share. The company’s revenue for the quarter was up 9.7% compared to the same quarter last year. On average, equities analysts anticipate that Marsh & McLennan Companies will post 8.64 earnings per share for the current year.

Insider Activity

In other news, VP Stacy Mills sold 1,461 shares of Marsh & McLennan Companies stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $209.16, for a total transaction of $305,582.76. Following the completion of the transaction, the vice president now directly owns 2,923 shares in the company, valued at $611,374.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, VP Stacy Mills sold 1,461 shares of Marsh & McLennan Companies stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $209.16, for a total transaction of $305,582.76. Following the completion of the transaction, the vice president now directly owns 2,923 shares in the company, valued at $611,374.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Dean Michael Klisura sold 9,994 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $205.00, for a total transaction of $2,048,770.00. Following the sale, the chief executive officer now directly owns 20,935 shares of the company’s stock, valued at approximately $4,291,675. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 36,751 shares of company stock worth $7,448,163. Insiders own 0.35% of the company’s stock.

Institutional Investors Weigh In On Marsh & McLennan Companies

Several institutional investors and hedge funds have recently made changes to their positions in the company. Charter Oak Capital Management LLC bought a new stake in shares of Marsh & McLennan Companies during the first quarter valued at approximately $216,000. Venturi Wealth Management LLC grew its position in Marsh & McLennan Companies by 28.1% in the 1st quarter. Venturi Wealth Management LLC now owns 6,532 shares of the financial services provider’s stock worth $1,345,000 after purchasing an additional 1,433 shares during the period. Bluesphere Advisors LLC bought a new stake in Marsh & McLennan Companies in the 1st quarter worth approximately $206,000. Summit Trail Advisors LLC grew its position in Marsh & McLennan Companies by 32.4% in the 1st quarter. Summit Trail Advisors LLC now owns 4,474 shares of the financial services provider’s stock worth $922,000 after purchasing an additional 1,094 shares during the period. Finally, Stablepoint Partners LLC bought a new stake in Marsh & McLennan Companies in the 1st quarter worth approximately $252,000. Institutional investors own 87.99% of the company’s stock.

About Marsh & McLennan Companies

Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services.